A Trial of AXS-05 in Patients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

June 20, 2019

Primary Completion Date

November 26, 2019

Study Completion Date

December 5, 2019

Conditions
DepressionMajor Depressive Disorder
Interventions
DRUG

AXS-05

Oral AXS-05 tablets, taken daily for 6 weeks.

DRUG

Placebo

Placebo to match oral AXS-05 tablets, taken daily for 6 weeks.

Trial Locations (43)

10312

Clinical Research Site, Staten Island

11432

Clinical Research Site, Jamaica

14618

Clinical Research Site, Rochester

19063

Clinical Research Site, Media

19104

Clinical Research Site, Philadelphia

28601

Clinical Research Site, Hickory

30328

Clinical Research Site, Atlanta

32256

Clinical Research Site, Jacksonville

32801

Clinical Research Site, Orlando

33024

Clinical Research Site, Hollywood

33067

Clinical Research Site, Coral Springs

33161

Clinical Research Site, North Miami

33319

Clinical Research Site, Lauderhill

38119

Clinical Research Site, Memphis

44130

Clinical Research Site, Middleburg Heights

45219

Clinical Research Site, Cincinnati

60634

Clinical Research Site, Chicago

72209

Clinical Research Site, Little Rock

73112

Clinical Research Site, Oklahoma City

75243

Clinical Research Site, Dallas

76104

Clinical Research Site, Fort Worth

76309

Clinical Research Site, Wichita Falls

77058

Clinical Research Site, Houston

83704

Clinical Research Site, Boise

85012

Clinical Research Site, Phoenix

85016

Clinical Research Site, Phoenix

89102

Clinical Research Site, Las Vegas

90210

Clinical Research Site, Beverly Hills

90706

Clinical Research Site, Bellflower

91402

Clinical Research Site, Panorama City

91403

Clinical Research Site, Sherman Oaks

91786

Clinical Research Site, Upland

92056

Clinical Research Site, Oceanside

92103

Clinical Research Site, San Diego

92374

Clinical Research Site, Redlands

92506

Clinical Research Site, Riverside

92845

Clinical Research Site, Garden Grove

94607

Clinical Research Site, Oakland

98201

Clinical Research Site, Everett

02131

Clinical Research Site, Boston

08009

Clinical Research Site, Berlin

08002

Clinical Research Site, Cherry Hill

08755

Clinical Research Site, Toms River

Sponsors
All Listed Sponsors
lead

Axsome Therapeutics, Inc.

INDUSTRY

NCT04019704 - A Trial of AXS-05 in Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter